Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / statera biopharma granted continued listing on nasda


STAB - Statera Biopharma granted continued listing on Nasdaq

  • Statera Biopharma ( NASDAQ: STAB ) on Thursday said a hearings panel had granted the company's request for continued listing on Nasdaq.
  • The continued listing was "subject to the company's satisfaction of certain interim milestones," STAB said in a statement .
  • The company would also have to comply with all criteria needed for continued listing, including the minimum bid price of $1.00 and $2.5M stockholder's equity requirements, by Jan. 31, 2023.
  • STAB stock +0.7% to $0.15 after hours.

For further details see:

Statera Biopharma granted continued listing on Nasdaq
Stock Information

Company Name: Statera Biopharma Inc.
Stock Symbol: STAB
Market: NASDAQ
Website: staterabiopharma.com

Menu

STAB STAB Quote STAB Short STAB News STAB Articles STAB Message Board
Get STAB Alerts

News, Short Squeeze, Breakout and More Instantly...